Variable | Number of participants (%) | Mean (SD) | Adjusted difference at follow-up* | |||
---|---|---|---|---|---|---|
Control | Intervention | Control | Intervention | Coefficient (95% CI) | P value | |
BMI (kg/m2) | 86 (80) | 69 (66) | 28.60 (5.15) | 28.29 (4.64) | − 0.36 (− 0.77 to 0.05) | 0.088 |
Body weight (kg) | 86 (80) | 69 (66) | 80.41 (17.43) | 79.88 (16.34) | − 0.99 (− 2.12 to 0.13) | 0.084 |
Waist circumference (cm) | 86 (80) | 69 (66) | 99.44 (13.96) | 98.22 (13.13) | − 2.55 (− 4.55 to − 0.55) | 0.013 |
Hip circumference (cm) | 86 (80) | 69 (66) | 107.39 (10.63) | 107.70 (9.75) | 0.79 (− 1.14 to 2.73) | 0.419 |
Systolic BP (mmHg) | 86 (80) | 69 (66) | 141.93 (19.04) | 137.55 (18.96) | − 4.19 (− 9.13 to 0.76) | 0.096 |
Diastolic BP (mmHg) | 86 (80) | 69 (66) | 85.00 (9.77) | 80.52 (10.88) | − 4.28 (− 6.98 to − 1.58) | 0.002 |
Total cholesterol (mmol/l) | 86 (80) | 69 (66) | 5.46 (1.01) | 5.21 (0.70) | − 0.21 (− 0.46 to 0.05) | 0.120 |
HDL cholesterol (mmol/l) | 86 (80) | 69 (66) | 1.65 (0.59) | 1.63 (0.45) | 0.01 (− 0.06 to 0.08) | 0.814 |
TC-to-HDL ratio | 86 (80) | 69 (66) | 3.59 (1.14) | 3.44 (1.04) | − 0.18 (− 0.40 to 0.05) | 0.128 |
CVD risk score | 86 (80) | 69 (66) | 17.06 (10.30) | 16.71 (9.20) | − 1.36 (− 3.28 to 0.56) | 0.165 |
Number of prescriptions | 99 (93) | 92 (88) | 10.80 (3.95) | 11.82 (3.62) | 0.98 (− 0.07 to 2.04) | 0.067 |